抗发作药物:药物开发的进展,挑战和前景
Yan Hong Ng1, Siti Nur Hidayah Jamil2,3, Murni Nazira Sarian4
1Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia.
Current neuropharmacology
|January 27, 2025
概括
本综述详细介绍了治疗抗发作药物 (ASM) 的最新进展,重点介绍了新型药物,如Everolimus和Cannabidiol. 它还讨论了药物耐药性和不良影响等挑战,以及未来的ASM发展战略.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 影响全球数百万人,抗发作药物 (ASM) 是治疗的基石.
- 有超过20种ASM在商业上可供使用,这反映了过去30年来治疗的重大进展.
研究的目的:
- 审查最近在市场上销售的ASM的传统和新型作用机制.
- 解决ASM发展的挑战,包括耐药性和不良影响.
- 探索ASM多疗法,理想的ASM特征以及未来的药物开发.
主要方法:
- 关于抗发作药物的科学文献的综述.
- 专注于Everolimus,Cannabidiol,Cenobamate,Fenfluramine和Ganaxolone的作用机制的研究.
- 对耐药,精神病/行为副作用和ASM多疗法的分析.
主要成果:
- 五个最近的ASM的机制的详细描述.
- 确定耐药性和不良影响是主要障碍.
- 讨论ASM多疗法的有效性,益处和挑战.
结论:
- 新型ASM提供了新的治疗途径,但面临着药物耐药性和副作用等挑战.
- 优化ASM多疗法和开发理想的ASM对于改善管理至关重要.
- 调节GABAAR,以异古瓦辛为例,代表了一个有希望的未来治疗策略.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Antiepileptic Drugs: GABAergic Pathway Potentiators
316
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
316
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
221
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
221
Antiepileptic Drugs: Sodium Channel Blockers
361
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
361
Antiepileptic Drugs: Glutamate Antagonists
273
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
273
Antiepileptic Drugs: Calcium Channel Blockers
298
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
298


